Savara Pharmaceuticals
SVRA
$4.09
Share price
-0.49%
Change (1 day)
39.59%
Change (1 year)
Categories
Operating Margin for Savara Pharmaceuticals (SVRA)
Operating Margin as of June 2024 (TTM): -9,013.13%
According to Savara Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -9,013.13%. At the end of 2020 the company had an Operating Margin of -19,305.45%.
Operating Margin history for Savara Pharmaceuticals from 2016 to 2020
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2020 | -19,305.45% | |
| 2016 | -30,085.16% | |
| 2010 | -1,746.51% | -53.74% |
| 2009 | -3,775.02% | -29.17% |
| 2008 | -5,329.50% | 20.35% |
| 2007 | -4,428.41% | |
| 2005 | -2,661.58% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -99.60% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -6.90% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.